Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis W King

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|September 19, 2009
Increasing the sample size at interim for a two-sample experiment without Type I error inflationKeith Dunnigan, Dennis W King
The Journal of Clinical Dentistry|March 13, 2002
A clinical investigation into the effect of toothbrush wear on efficacyPaul R Warren, Diane Jacobs, Mari-Anne Low, et al.
American Journal of Dentistry|April 15, 2003
A clinical study of plaque removal with an advanced rechargeable power toothbrush and a battery-operated deviceMatthew J Cronin, Wayne Z Dembling, Dennis W King, et al.
Journal of Industrial Microbiology & Biotechnology|May 4, 2005
Laboratory evaluation of oil spill bioremediation products in salt and freshwater systemsJohn R Haines, Eric J Kleiner, Kim A McClellan, et al.
Clinical & Experimental Metastasis|June 26, 2012
The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of careChristopher A Tokin, Frederick O Cope, Wendy L Metz, et al.
Annals of Surgical Oncology|October 12, 2012
Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanomaVernon K Sondak, Dennis W King, Jonathan S Zager, et al.
Annals of Surgical Oncology|March 19, 2013
Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trialsAnne M Wallace, Linda K Han, Stephen P Povoski, et al.
Annals of Surgical Oncology|February 12, 2015
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional TrialAmit Agrawal, Francisco J Civantos, Kevin T Brumund, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|September 19, 2009
Increasing the sample size at interim for a two-sample experiment without Type I error inflationKeith Dunnigan, Dennis W King
The Journal of Clinical Dentistry|March 13, 2002
A clinical investigation into the effect of toothbrush wear on efficacyPaul R Warren, Diane Jacobs, Mari-Anne Low, et al.
American Journal of Dentistry|April 15, 2003
A clinical study of plaque removal with an advanced rechargeable power toothbrush and a battery-operated deviceMatthew J Cronin, Wayne Z Dembling, Dennis W King, et al.
Journal of Industrial Microbiology & Biotechnology|May 4, 2005
Laboratory evaluation of oil spill bioremediation products in salt and freshwater systemsJohn R Haines, Eric J Kleiner, Kim A McClellan, et al.
Clinical & Experimental Metastasis|June 26, 2012
The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of careChristopher A Tokin, Frederick O Cope, Wendy L Metz, et al.
Annals of Surgical Oncology|October 12, 2012
Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanomaVernon K Sondak, Dennis W King, Jonathan S Zager, et al.
Annals of Surgical Oncology|March 19, 2013
Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trialsAnne M Wallace, Linda K Han, Stephen P Povoski, et al.
Annals of Surgical Oncology|February 12, 2015
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional TrialAmit Agrawal, Francisco J Civantos, Kevin T Brumund, et al.
Pageof 1